Research Paper Volume 15, Issue 12 pp 5304—5338
Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma
Figure 7. Tumor mutation burden in different risk groups. Percentage bar graph showing TMB for different risk subgroups (A); High-risk group waterfall chart (B); Low-risk group waterfall chart (C).